Russell Investments Group, Ltd. Incyte Corp Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 521,254 shares of INCY stock, worth $36.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

521,254

Previous 625,880 16.72%

Holding current value

$36.4 Million

Previous $37.9 Million 9.19%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $6 Million - $7.18 Million	-104,626 Reduced 16.72%	521,254 $34.5 Million
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $20.9 Million - $26 Million	-407,677 Reduced 39.44%	625,880 $37.9 Million
Q1 2024 May 08, 2024	BUY	$56.55 - $66.59 $3.98 Million - $4.69 Million	70,467 Added 7.32%	1,033,557 $58.9 Million
Q4 2023 Feb 05, 2024	BUY	$52.16 - $64.19 $11.4 Million - $14 Million	217,979 Added 29.25%	963,090 $60.5 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $10.2 Million - $11.6 Million	175,844 Added 30.89%	745,111 $43 Million
Q2 2023 Aug 10, 2023	SELL	$60.95 - $75.51 $6.96 Million - $8.62 Million	-114,122 Reduced 16.7%	569,267 $35.4 Million
Q1 2023 May 09, 2023	BUY	$70.23 - $86.01 $888,269 - $1.09 Million	12,648 Added 1.89%	683,389 $49.4 Million
Q4 2022 Feb 08, 2023	SELL	$67.18 - $84.11 $3.48 Million - $4.36 Million	-51,825 Reduced 7.17%	670,741 $53.9 Million
Q3 2022 Nov 04, 2022	BUY	$66.18 - $82.86 $19.7 Million - $24.7 Million	298,348 Added 70.33%	722,566 $48.1 Million
Q2 2022 Jul 29, 2022	SELL	$66.18 - $83.18 $431,692 - $542,583	-6,523 Reduced 1.51%	424,218 $32.2 Million
Q1 2022 May 05, 2022	BUY	$66.02 - $79.71 $9.78 Million - $11.8 Million	148,148 Added 52.42%	430,741 $34.2 Million
Q4 2021 Jan 21, 2022	BUY	$63.34 - $74.11 $5.21 Million - $6.1 Million	82,321 Added 41.1%	282,593 $20.7 Million
Q3 2021 Nov 08, 2021	SELL	$68.67 - $84.02 $1.53 Million - $1.87 Million	-22,307 Reduced 10.02%	200,272 $13.8 Million
Q2 2021 Aug 04, 2021	BUY	$79.87 - $87.53 $913,952 - $1 Million	11,443 Added 5.42%	222,579 $18.7 Million
Q1 2021 May 10, 2021	BUY	$76.02 - $100.5 $1.77 Million - $2.34 Million	23,295 Added 12.4%	211,136 $17.2 Million
Q4 2020 Feb 08, 2021	SELL	$80.74 - $97.7 $312,706 - $378,392	-3,873 Reduced 2.02%	187,841 $16.3 Million
Q3 2020 Nov 09, 2020	BUY	$85.07 - $109.69 $9.9 Million - $12.8 Million	116,432 Added 154.66%	191,714 $17.1 Million
Q2 2020 Aug 05, 2020	SELL	$74.18 - $108.93 $11.1 Million - $16.4 Million	-150,163 Reduced 66.61%	75,282 $7.81 Million
Q1 2020 May 06, 2020	BUY	$63.18 - $85.97 $5.15 Million - $7.01 Million	81,590 Added 56.72%	225,445 $16.4 Million
Q4 2019 Jan 29, 2020	BUY	$73.04 - $95.72 $5.29 Million - $6.93 Million	72,390 Added 101.29%	143,855 $12.6 Million
Q3 2019 Nov 01, 2019	BUY	$72.82 - $86.52 $2.76 Million - $3.28 Million	37,897 Added 112.9%	71,465 $5.27 Million
Q2 2019 Aug 09, 2019	SELL	$73.52 - $88.7 $8.08 Million - $9.75 Million	-109,908 Reduced 76.6%	33,568 $2.85 Million
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $2.7 Million - $3.75 Million	42,558 Added 42.17%	143,476 $12.3 Million
Q4 2018 Feb 11, 2019	BUY	$58.5 - $69.94 $2.94 Million - $3.52 Million	50,293 Added 99.34%	100,918 $6.41 Million
Q3 2018 Oct 26, 2018	BUY	$61.75 - $74.23 $2.4 Million - $2.89 Million	38,898 Added 331.7%	50,625 $3.5 Million
Q2 2018 Aug 08, 2018	SELL	$60.85 - $83.98 $3.86 Million - $5.33 Million	-63,423 Reduced 84.4%	11,727 $782,000
Q1 2018 May 11, 2018	BUY	$83.06 - $100.98 $3.12 Million - $3.79 Million	37,541 Added 99.82%	75,150 $6.27 Million
Q4 2017 Feb 06, 2018	BUY	$93.56 - $116.6 $323,436 - $403,086	3,457 Added 10.12%	37,609 $3.59 Million
Q3 2017 Nov 07, 2017	BUY	$109.15 - $138.27 $3.73 Million - $4.72 Million	34,152	34,152 $3.99 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Incyte Corp Transaction History